Earnings call transcript: B3 reports record Q1 2026 results, beats EPS forecast

B3 reported record Q1 2026 revenue of BRL 3.2 billion, up 21% year over year, with recurring EBITDA of BRL 2.1 billion (+24%), recurring net income of BRL 1.5 billion (+33%), and EPS of BRL 0.30, an 8.26% beat versus estimates. Shares rose 0.96% after the release as management highlighted strong foreign inflows, operational leverage, and continued product expansion, while also confirming a CEO transition by end-June 2026. The call also emphasized ongoing regulatory work on new products and receivables registration, plus a bias toward dividends over buybacks if the stock remains elevated.

Analysis

The market is still underestimating how much of this is a duration trade on Brazilian risk assets rather than just a one-quarter earnings beat. When foreign inflows and volatility rise together, B3 monetizes both sides of the tape: higher turnover today and a stronger product-launch pipeline tomorrow, which is why this looks more like an earnings-quality inflection than a cyclical spike. The key second-order effect is that a healthier capital-markets backdrop can re-rate adjacent financial infrastructure and brokerage exposures even if primary issuance remains uneven.

The bigger medium-term issue is mix. The quarter benefited from unusually favorable short-dated volatility, which is not repeatable at the same intensity, so the next leg of upside will likely come from structurally recurring lines and from converting new product launches into broader distribution. That puts regulatory approvals and client-access expansion at the center of the debate; if those gates stay closed, the innovation narrative contributes to option value but not near-term numbers.

On governance, the CEO transition is not a fundamental earnings risk yet, but it does create a window where the market may demand a higher discount rate on execution. The more important hidden catalyst is capital return: as the share price has appreciated, management is effectively signaling that buybacks are less attractive than cash payouts, which should support near-term yield support and reduce downside in the stock. The contrarian view is that consensus may be overpricing the sustainability of March-like activity while underpricing the compounding effect of data, infrastructure, and new contract monetization over 12-24 months.

Key Decisions for Investors

• Long B3SA3 on pullbacks over the next 2-4 weeks; use the recent print as evidence of operating leverage, with a 10-15% upside target if foreign-flow momentum persists and a tight stop below the post-earnings reaction low.
• Pair trade: long B3SA3 / short a Brazil beta proxy with less fee leverage to trading volumes over 1-3 months, betting that market infrastructure captures more of the active-market upside than broad financials.
• Buy limited-risk upside via call spreads in B3SA3 for 3-6 months; the setup benefits from a rerating on recurring revenue durability and capital return, while capping downside if activity normalizes.
• Avoid chasing the move in the near term if you expect volatility to mean-revert after the geopolitical spike; instead, wait for a 5-7% retracement to add, since the stock likely needs a better entry after the market digests peak-quarter expectations.
• Monitor regulatory headlines on new products and receivables registration; if access broadens or the assisted-live phase progresses without friction, add tactically because that is the cleanest catalyst for a second leg higher over 6-12 months.